Page last updated: 2024-08-26

1,4-dihydropyridine and Heart Disease, Ischemic

1,4-dihydropyridine has been researched along with Heart Disease, Ischemic in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (87.50)	18.2507
2000's	1 (12.50)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mielcarek, J; Naskrent, M	1
Furberg, CD; Meyer, JV; Psaty, BM	1
Vetrovec, GW	1
Beevers, DG; Sleight, P	1
Ehring, T; Heusch, G	1
Blanck, TJ; Curtis, WE; Gardner, TJ; Quigg, M; Yasukochi, S	1
Bassett, AL; Chakko, S; Epstein, M	1
Hoshi, K; Ichihara, K; Satoh, K; Yamamoto, A	1

Reviews

3 review(s) available for 1,4-dihydropyridine and Heart Disease, Ischemic

Article	Year
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation, 1995, Sep-01, Volume: 92, Issue:5 Topics: Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Confidence Intervals; Coronary Disease; Depression, Chemical; Dihydropyridines; Dose-Response Relationship, Drug; Hemorrhage; Humans; Hypotension; Myocardial Contraction; Myocardial Ischemia; Nifedipine; Odds Ratio; Renin-Angiotensin System; Sympathetic Nervous System; Time Factors	1995
Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk? BMJ (Clinical research ed.), 1996, May-04, Volume: 312, Issue:7039 Topics: Calcium Channel Blockers; Case-Control Studies; Clinical Trials as Topic; Dihydropyridines; Humans; Hypertension; Myocardial Ischemia; Nifedipine; Sensitivity and Specificity	1996
Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion? Cardiology, 1997, Volume: 88 Suppl 1 Topics: Animals; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Dihydropyridines; Dogs; Humans; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardial Stunning; Nisoldipine; Vasoconstriction	1997

Other Studies

5 other study(ies) available for 1,4-dihydropyridine and Heart Disease, Ischemic

Article	Year
The effect of ionizing radiation of 1,4-dihydropyridine derivatives in the solid state. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2007, Volume: 67, Issue:1 Topics: Calcium Channel Blockers; Dihydropyridines; Electron Spin Resonance Spectroscopy; Felodipine; Gamma Rays; Humans; Hypertension; Models, Molecular; Molecular Conformation; Myocardial Ischemia; Nifedipine; Nimodipine	2007
Hemodynamic and electrophysiologic effects of first- and second-generation calcium antagonists. The American journal of cardiology, 1994, Jan-27, Volume: 73, Issue:3 Topics: Amlodipine; Calcium Channel Blockers; Cardiac Output; Dihydropyridines; Electrophysiology; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Myocardial Contraction; Myocardial Ischemia; Ventricular Function, Left	1994
Global ischemia increases the density of voltage-dependent calcium channels in porcine cardiac sarcolemma. Anesthesia and analgesia, 1997, Volume: 84, Issue:5 Topics: 5'-Nucleotidase; Animals; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Heart Ventricles; In Vitro Techniques; Isradipine; Myocardial Ischemia; Myocardium; Sarcolemma; Swine	1997
Are calcium antagonists proarrhythmic? Journal of hypertension, 1997, Volume: 15, Issue:9 Topics: Arrhythmias, Cardiac; Blood Pressure; Calcium; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Heart; Humans; Myocardial Ischemia; Prospective Studies; Risk Factors	1997
Effects of azelnidipine, a dihydropyridine calcium antagonist, on myocardial stunning in dogs. Japanese journal of pharmacology, 1998, Volume: 76, Issue:4 Topics: Animals; Atropine; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Dogs; Female; Heart; Hemodynamics; Male; Myocardial Contraction; Myocardial Ischemia; Propranolol	1998